These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33420287)

  • 1. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA.
    Zu Y; Zhou J; Fu Y; Fang B; Liu X; Zhang Y; Yu F; Zuo W; Zhou H; Gui R; Li Z; Liu Y; Zhao H; Zhang C; Song Y
    Sci Rep; 2021 Jan; 11(1):253. PubMed ID: 33420287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
    Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
    Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
    Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.
    Xu L; Liu Z; Wu Y; Yang X; Cao Y; Li X; Yan B; Li S; Da W; Wu X
    Eur J Med Res; 2018 Mar; 23(1):12. PubMed ID: 29490698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
    George B; Pn N; Devasia AJ; Kulkarni U; Korula A; Lakshmi KM; Abraham A; Srivastava A; Mathews V
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):494-500. PubMed ID: 29100905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
    Ahmed S; Kanakry JA; Ahn KW; Litovich C; Abdel-Azim H; Aljurf M; Bacher VU; Bejanyan N; Cohen JB; Farooq U; Fuchs EJ; Bolaños-Meade J; Ghosh N; Herrera AF; Hossain NM; Inwards D; Kanate AS; Martino R; Munshi PN; Murthy H; Mussetti A; Nieto Y; Perales MA; Romee R; Savani BN; Seo S; Wirk B; Yared JA; Sureda A; Fenske TS; Hamadani M
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1859-1868. PubMed ID: 31132455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia.
    Nagler A; Labopin M; Dholaria B; Angelucci E; Afanasyev B; Cornelissen JJ; Sica S; Meijer E; Ciceri F; Van Gorkom G; Kröger N; Martin H; Pioltelli P; Risitano A; Canaani J; Savani BN; Sanz J; Mohty M
    Clin Cancer Res; 2021 Feb; 27(3):843-851. PubMed ID: 33148668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
    Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
    Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation.
    Wu L; Zhou M; Li Y; Chen X; Mo W; Wang C; Xu S; Zhou W; Deng T; Zhou R; Pan S; Wang S; Zhang Y
    Transplant Cell Ther; 2023 Jul; 29(7):463.e1-463.e7. PubMed ID: 37098408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
    Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
    Front Immunol; 2022; 13():837335. PubMed ID: 35178053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Dose Anti-Thymocyte Globulin Plus Low-Dose Posttransplant Cyclophosphamide as an Effective Regimen for Prophylaxis of Graft
    Li T; He Q; Yang J; Cai Y; Huang C; Xu X; Qiu H; Niu J; Zhou K; Zhang Y; Xia X; Wei Y; Shen C; Ding X; Tong Y; Wan L; Song X
    Cell Transplant; 2022; 31():9636897221139103. PubMed ID: 36433646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
    Elmariah H; Otoukesh S; Kumar A; Ali H; Arslan S; Shouse G; Pourhassan H; Nishihori T; Faramand R; Mishra A; Khimani F; Fernandez H; Lazaryan A; Nieder M; Perez L; Liu H; Nakamura R; Pidala J; Marcucci G; Forman SJ; Anasetti C; Locke F; Bejanyan N; Al Malki MM
    Transplant Cell Ther; 2024 Feb; 30(2):229.e1-229.e11. PubMed ID: 37952648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu
    Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
    Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients.
    Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H
    Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia.
    Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide.
    Fu A; Peng Y; Cheng P; Wu J; Zhu X; Yang Y; Huang L; Wang N; Wang J; Xu J; Wan Y; Cao Y; Wei J; Xiao Y; Meng F; Cheng H; Zhang Y; Zhang D
    Transplant Cell Ther; 2024 May; 30(5):500-509. PubMed ID: 38447750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.